Neurological Disorders Diagnostics Market – Development of New Diagnostic Tools is Expected to Drive Market Growth
The diagnosis of neurological disorders is a rapidly expanding field of biotechnology research that focuses on understanding how living systems influence each other.
SEATTLE, WASHINGTON, USA, November 18, 2021 /EINPresswire.com/ – Market Snapshot:
The diagnosis of neurological disorders is a rapidly expanding field of biotechnology research that focuses on understanding how living systems affect each other and how neurological disorders can elicit biochemical, genetic or cellular responses. that affect other biochemical systems in the body. With the advancement of technology and associated science, diagnostic tests for neurological disorders have become increasingly effective. Neurological Disorder Diagnostic Tools are specialized instruments used to diagnose various neurological conditions. These instruments allow researchers and clinicians to draw precise conclusions about neurological dysfunctions and their consequences.
Get Sample Report With Latest Information @ https://www.coherentmarketinsights.com/insight/request-sample/1867
The main players involved in the market are Koninklijke Philips NV, Siemens Healthineers, General Electric Company, Esaote SpA, Masimo Corporation, NeuroLogica Corporation, Neusoft Medical Systems, York Instruments Ltd. and Canon Medical Systems Corporation
Main market drivers:
The increasing prevalence of neurological disorder is a prime factor in the growth of the neurological disorder diagnostics market. According to the Pan American Health Organization, in 2019, regional neurological conditions were responsible for 533,172 deaths, 213,129 (40%) in men and 320,043 (60%) in women. 32.9 deaths per 100,000 population (age-standardized), 33.1 deaths per 100,000 population for males and 32.2 deaths per 100,000 population for females. Additionally, according to data released by the Alzheimer’s Association in 2018, approximately 5.7 million people in the United States of all age groups suffered from Alzheimer’s disease and dementia in 2017.
The increase in government initiatives to educate the public about neurological disorders is expected to promote the growth of the market. For example, in September 2018, the Indian government introduced social protection programs, such as Ayushmann Bharat — Pradhan Mantri Jan Arogya Yojna, for various illnesses, including neurological disorders.
Request a PDF brochure with the latest information @ https://www.coherentmarketinsights.com/insight/request-pdf/1867
Covid-19 impact assessment
During the pandemic, there is a high demand for diagnoses of neurological disorders, as infection with Covid-19 has a detrimental effect on the brain. These devices were increasingly in demand to analyze the impact of Covid-19 on a patient’s brain. Thus, the neurological disorder diagnostics market has experienced strong growth during a pandemic.
Key points to remember:
The Neurological Disorders Diagnostics market is expected to post a XX% CAGR during the forecast period, increasing the investments of major players in neurological diagnostic devices. For example, in January 2021, Manus Neurodynamica, a medical technology company, raised £ 1.2million ($ 1.6million) to launch NeuroMotor, a digital pen with patented sensor technology that can help diagnose patients with Parkinson’s disease and other movement disorders.
North America is expected to experience significant growth during the forecast period which is attributed to the increasing launch of innovative and high performance diagnostic devices. For example, in January 2021, Abbott announced the launch of NeuroSphere ™ myPath ™, a digital health application designed to track and report on patient perceived pain relief and overall well-being associated with stimulation of the patient’s body. spinal cord (SCS) or dorsal root ganglion (DRG). ) therapy.
Purchase this premium report to access all information @ https://www.coherentmarketinsights.com/insight/buy-now/1867
Chapter 1 Industry Overview
1.3 Scope of the research
1.4 Market Analysis by Regions
1.5 Global Neurological Disorders Diagnostics Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Impact on Neurological Disorders Diagnostics Industry
Chapter 2 Global Neurological Disorders Diagnosis Competition by Types, Applications and Major Regions and Countries
2.1 Global Diagnosis of Neurological Disorders (Volume & Value) by Type
2.3 Global diagnosis of neurological disorders (volume and value) by regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional production market analysis
Chapter 4 Global Sales, Consumption, Export, Import of Neurological Disorders Diagnosis by Regions (2016-2021)
Chapter 5 North America Neurological Disorders Diagnostics Market Analysis
Chapter 6 East Asia Neurological Disorders Diagnostics Market Analysis
Chapter 7 Europe Neurological Disorders Diagnostics Market Analysis
Chapter 8 South Asia Neurological Disorders Diagnostics Market Analysis
Chapter 9 Southeast Asia Neurological Disorders Diagnostics Market Analysis
Chapter 10 Middle East Neurological Disorders Diagnostics Market Analysis
Chapter 11 Africa Neurological Disorders Diagnostics Market Analysis
Chapter 12 Oceania Neurological Disorders Diagnostics Market Analysis
Chapter 13 South America Neurological Disorders Diagnostics Market Analysis
Chapter 14 Company Profiles and Key Figures of Neurological Disorders Diagnostics Industry
Chapter 15 Global Neurological Disorders Diagnostics Market Forecast (2021-2027)
Chapter 16 Conclusions
Consistent market information
1001 4th Ave, # 3200 Seattle, WA 98154, USA
Email: [email protected]
United States of America: + 1-206-701-6702
United Kingdom: + 44-020-8133-4027
Japan: + 050-5539-1737
India: + 91-848-285-0837
Coherent Market Insights Pvt. Ltd.
write us here
Visit us on social networks: